BLTE: Belite Bio Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Belite Bio Inc (BLTE).
$1.84B Market Cap.
BLTE Market Cap. (MRY)
BLTE Shares Outstanding (MRY)
BLTE Assets (MRY)
Total Assets
$152.13M
Total Liabilities
$6.31M
Total Investments
$113.47M
BLTE Income (MRY)
Revenue
$0
Net Income
-$36.14M
Operating Expense
$40.00M
BLTE Cash Flow (MRY)
CF Operations
-$29.23M
CF Investing
-$110.57M
CF Financing
$83.59M
BLTE Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $152,132,000 (60.74%) | $94,642,000 (113.77%) | $44,273,000 (141.30%) | $18,348,000 (-28.72%) |
Assets Current | $147,073,000 (63.52%) | $89,940,000 (110.11%) | $42,807,000 (145.58%) | $17,431,000 (-32.09%) |
Assets Non-Current | $5,059,000 (7.59%) | $4,702,000 (220.74%) | $1,466,000 (59.87%) | $917,000 (1156.16%) |
Goodwill & Intangible Assets | $31,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $145,821,000 (61.25%) | $90,431,000 (117.90%) | $41,501,000 (374.97%) | -$15,093,000 (-114.48%) |
Property Plant & Equipment Net | $965,000 (-25.83%) | $1,301,000 (-5.59%) | $1,378,000 (1365.96%) | $94,000 (42.42%) |
Cash & Equivalents | $31,677,000 (-64.07%) | $88,157,000 (109.45%) | $42,089,000 (142.67%) | $17,344,000 (-32.30%) |
Accumulated Other Comprehensive Income | -$660,000 (-76.47%) | -$374,000 (4.59%) | -$392,000 (-100.00%) | -$196,000 (-345.45%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $113,472,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $113,472,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $575,000 (-31.22%) | $836,000 (41700.00%) | $2,000 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $13,000 (0%) | $0 (0%) | $0 (0%) | $71,000 (173.08%) |
Accumulated Retained Earnings (Deficit) | -$107,647,000 (-50.55%) | -$71,503,000 (-79.34%) | -$39,871,000 (-46.46%) | -$27,223,000 (-55.05%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $537,000 (-39.39%) | $886,000 (2.31%) | $866,000 (0%) | $0 (0%) |
Debt Current | $276,000 (-10.39%) | $308,000 (55.56%) | $198,000 (0%) | $0 (0%) |
Debt Non-Current | $261,000 (-54.84%) | $578,000 (-13.47%) | $668,000 (0%) | $0 (0%) |
Total Liabilities | $6,311,000 (49.87%) | $4,211,000 (51.91%) | $2,772,000 (69.54%) | $1,635,000 (68.21%) |
Liabilities Current | $6,050,000 (66.53%) | $3,633,000 (72.67%) | $2,104,000 (28.69%) | $1,635,000 (68.21%) |
Liabilities Non-Current | $261,000 (-54.84%) | $578,000 (-13.47%) | $668,000 (0%) | $0 (0%) |
BLTE Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $10,057,000 (47.38%) | $6,824,000 (72.67%) | $3,952,000 (66.19%) | $2,378,000 (15.72%) |
Research & Development Expense | $29,939,000 (20.51%) | $24,844,000 (180.12%) | $8,869,000 (19.54%) | $7,419,000 (101.17%) |
Operating Expenses | $39,996,000 (26.30%) | $31,668,000 (147.00%) | $12,821,000 (30.87%) | $9,797,000 (70.59%) |
Interest Expense | $20,000 (-20.00%) | $25,000 (56.25%) | $16,000 (0%) | $0 (0%) |
Income Tax Expense | $6,000 (-33.33%) | $9,000 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$36,144,000 (-14.26%) | -$31,632,000 (-150.09%) | -$12,648,000 (-30.85%) | -$9,666,000 (-68.02%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$36,144,000 (-14.26%) | -$31,632,000 (-150.09%) | -$12,648,000 (-30.85%) | -$9,666,000 (-68.02%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$36,144,000 (-14.26%) | -$31,632,000 (-150.09%) | -$12,648,000 (-30.85%) | -$9,666,000 (-68.02%) |
Weighted Average Shares | $30,538,378 (14.83%) | $26,593,673 (33.12%) | $19,976,596 (108.74%) | $9,569,932 (8.87%) |
Weighted Average Shares Diluted | $30,538,378 (14.83%) | $26,593,673 (33.12%) | $19,976,596 (108.74%) | $9,569,932 (8.87%) |
Earning Before Interest & Taxes (EBIT) | -$36,118,000 (-14.30%) | -$31,598,000 (-150.14%) | -$12,632,000 (-30.68%) | -$9,666,000 (-68.66%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$39,996,000 (-26.30%) | -$31,668,000 (-147.00%) | -$12,821,000 (-30.87%) | -$9,797,000 (-70.59%) |
BLTE Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$110,572,000 (-175411.11%) | -$63,000 (84.01%) | -$394,000 (-603.57%) | -$56,000 (-180.00%) |
Net Cash Flow from Financing | $83,595,000 (10.05%) | $75,959,000 (105.50%) | $36,963,000 (6440.14%) | -$583,000 (-102.08%) |
Net Cash Flow from Operations | -$29,234,000 (2.02%) | -$29,837,000 (-160.40%) | -$11,458,000 (-53.30%) | -$7,474,000 (-68.26%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$56,480,000 (-222.60%) | $46,068,000 (86.17%) | $24,745,000 (399.07%) | -$8,274,000 (-135.06%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$110,421,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$116,000 (-84.13%) | -$63,000 (84.01%) | -$394,000 (-603.57%) | -$56,000 (-180.00%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $83,201,000 (7.79%) | $77,189,000 (103.17%) | $37,993,000 (16276.29%) | $232,000 (-60.41%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$269,000 (-3088.89%) | $9,000 (102.46%) | -$366,000 (-127.33%) | -$161,000 (-4125.00%) |
Share Based Compensation | $8,987,000 (135.08%) | $3,823,000 (157.79%) | $1,483,000 (-3.07%) | $1,530,000 (12.25%) |
Depreciation Amortization & Accretion | $449,000 (12.53%) | $399,000 (101.52%) | $198,000 (560.00%) | $30,000 (76.47%) |
BLTE Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -30.60% (36.25%) | -48.00% (49.90%) | -95.80% (-209.61%) | 87.40% |
Return on Average Assets (ROAA) | -29.30% (35.60%) | -45.50% (-12.62%) | -40.40% (7.76%) | -43.80% |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -60.90% (95.49%) | -1349.20% (83.18%) | -8020.30% (-714.02%) | 1306.20% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -53.48 (-39.09%) | -38.45 (19.65%) | -47.85 | - |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 12.61 (0.13%) | 12.6 (-28.03%) | 17.5 | - |
Debt to Equity Ratio (D/E) | 0.04 (-8.51%) | 0.05 (-29.85%) | 0.07 (162.04%) | -0.11 (21.74%) |
Earnings Per Share (EPS) | -1.18 (0.84%) | -1.19 (-88.89%) | -0.63 (37.62%) | -1.01 (-55.38%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.96 (14.50%) | -1.12 (-89.54%) | -0.59 (24.65%) | -0.79 (-54.92%) |
Book Value Per Share (BVPS) | 4.78 (40.44%) | 3.4 (63.70%) | 2.08 (231.71%) | -1.58 (-96.88%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.98 (39.96%) | 3.56 (60.60%) | 2.22 (15.60%) | 1.92 (-34.53%) |
Enterprise Value Over EBIT (EV/EBIT) | -49 (-40.00%) | -35 (37.50%) | -56 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -49.12 (-39.59%) | -35.19 (38.29%) | -57.02 | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 |
Current Ratio | 24.31 (-1.80%) | 24.76 (21.68%) | 20.35 (90.85%) | 10.66 (-59.63%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$29,350,000 (1.84%) | -$29,900,000 (-152.28%) | -$11,852,000 (-57.40%) | -$7,530,000 (-68.76%) |
Enterprise Value (EV) | $1,752,058,916 (59.58%) | $1,097,902,041 (54.85%) | $709,009,331 | - |
Earnings Before Tax (EBT) | -$36,138,000 (-14.28%) | -$31,623,000 (-150.02%) | -$12,648,000 (-30.85%) | -$9,666,000 (-68.05%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$35,669,000 (-14.33%) | -$31,199,000 (-150.92%) | -$12,434,000 (-29.04%) | -$9,636,000 (-68.64%) |
Invested Capital | $114,911,000 (2974.13%) | $3,738,000 (295.14%) | $946,000 (249.92%) | -$631,000 (25.68%) |
Working Capital | $141,023,000 (63.40%) | $86,307,000 (112.04%) | $40,703,000 (157.68%) | $15,796,000 (-36.04%) |
Tangible Asset Value | $152,101,000 (60.71%) | $94,642,000 (113.77%) | $44,273,000 (141.30%) | $18,348,000 (-28.72%) |
Market Capitalization | $1,839,329,916 (61.47%) | $1,139,125,041 (56.83%) | $726,353,331 | - |
Average Equity | $118,126,000 (79.07%) | $65,966,000 (399.59%) | $13,204,000 (219.33%) | -$11,065,000 |
Average Assets | $123,387,000 (77.64%) | $69,457,500 (121.83%) | $31,310,500 (42.03%) | $22,044,500 |
Invested Capital Average | $59,324,500 (2433.07%) | $2,342,000 (1386.98%) | $157,500 (121.28%) | -$740,000 |
Shares | 29,149,444 (17.07%) | 24,898,908 (3.34%) | 24,095,317 (0.00%) | 24,095,317 |
